1. Recent advances in the synthesis of extensive libraries of heparan sulfate oligosaccharides for structure-activity relationship studies.
- Author
-
Ramadan S, Mayieka M, Pohl NLB, Liu J, Hsieh-Wilson LC, and Huang X
- Subjects
- Structure-Activity Relationship, Humans, Animals, Small Molecule Libraries chemical synthesis, Small Molecule Libraries chemistry, Small Molecule Libraries pharmacology, Heparitin Sulfate chemistry, Heparitin Sulfate chemical synthesis, Oligosaccharides chemistry, Oligosaccharides chemical synthesis
- Abstract
Heparan sulfate (HS) is a linear, sulfated and highly negatively-charged polysaccharide that plays important roles in many biological events. As a member of the glycosaminoglycan (GAG) family, HS is commonly found on mammalian cell surfaces and within the extracellular matrix. The structural complexities of natural HS polysaccharides have hampered the comprehension of their biological functions and structure-activity relationships (SARs). Although the sulfation patterns and backbone structures of HS can be major determinants of their biological activities, obtaining significant amounts of pure HS from natural sources for comprehensive SAR studies is challenging. Chemical and enzyme-based synthesis can aid in the production of structurally well-defined HS oligosaccharides. In this review, we discuss recent innovations enabling the syntheses of large libraries of HS and how these libraries can provide insights into the structural preferences of various HS binding proteins., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Xuefei Huang reports financial support was provided by National Institutes of Health. Jian Liu reports financial support was provided by National Institutes of Health. Nicola Pohl reports financial support was provided by National Institutes of Health. Linda Hsieh-wilson reports financial support was provided by National Institutes of Health. Jian Liu reports a relationship with Glycan Therapeutics, LLC that includes: equity or stocks. Xuefei Huang reports a relationship with Glycan Therapeutics, LLC that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF